Join our Boehringer Ingelheim-sponsored Product Theater to hear more about the role of the liver in metabolic dysfunction, including a discussion on the broader impact beyond the liver from a leading endocrinologist. Our esteemed panel will also highlight the latest in MASLD/MASH patient management and answer your questions.

Industry Supporter: Boehringer Ingelheim Pharmaceuticals, Inc.

Dr. Gunn bridges MASH clinical trials with communities in dire need, and has authored numerous peer-reviewed journal articles. She trained at the University of Florida College of Medicine and completed fellowships in gastroenterology and hepatology. Dr. Gunn earned the rank of U.S. Air Force Major and was Chief of Gastroenterology at Eglin Air Force Base in Florida. She founded Impact Research Institute, has taught at Texas A&M and Dell College of Medicine at UT Austin, and is an adjunct faculty member at Baylor University. Dr.

Education:
• MD: Jefferson Medical College of Thomas Jefferson University (2008)
Postgraduate Training:
• Intern: Albert Einstein Medical Center, Transitional Internship (2009)
• Resident: Thomas Jefferson University Hospital, Radiology (2013)
• Fellow: Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital), Interventional Radiology (2014)
Certification:
• Board Certification: Interventional Radiology and Diagnostic Radiology, American Board of Radiology

Eric Lawitz, MD is the Medical Director and VP of Research and Development at the Texas Liver Institute and Professor of Medicine at the University of Texas Health San Antonio in San Antonio, Texas, USA. He began his career by achieving a BS from the University of Illinois and an MD from Rush Medical College, both in Chicago, before receiving postgraduate training in Gastroenterology and Hepatology at Brooke Army Medical Center in San Antonio, Texas, where he subsequently became Chief of Clinical Services.

Ashwini Mehta, DO, is a Texas native that earned her medical degree from Touro University Nevada and completed her residency at Medical City Fort Worth. There she was awarded the high honor of serving as Chief Resident, and was recognized with the Resident of the Year award. Dr. Mehta continued to pursue specialized training following her residency, and as a result of her outstanding work, she was deemed Fellow of the Year during her Gastroenterology Fellowship which was also at Medical City Fort Worth. Additionally, Dr.

Leigh Perreault, MD, FACE, FACP is an endocrinologist and Associate Professor of Medicine striving to transform our current approach to weight management and type 2 diabetes. Dr. Perreault graduated from the University of Southern California Keck School of Medicine and completed her residency in Internal Medicine and fellowship in Endocrinology, Metabolism and Diabetes at the University of Colorado where she has remained on faculty for the past 22 years. Dr.

David Wyles, MD, FIDSA is a Senior Director in US Medical Affairs at Gilead Sciences, where he supports strategic medical affairs initiatives in liver disease and viral hepatitis. In his current role he collaborates with internal and external stakeholders to advance scientific understanding, support evidence-based medical decision-making, and develop research initiatives that address unmet needs in liver disease.

Lance L Stein MD is the Medical Director of Hepatology and Transplant at Piedmont Atlanta Hospital. Clinical Asst Prof of Medicine at Mercer University School of Medicine